A citation-based method for searching scientific literature

Kristian Reich, Lars Erik Kristensen, Saxon D Smith, Phoebe Rich, Christophe Sapin, Soyi Liu Leage, Robert McKenzie, Christopher Schuster, Elisabeth Riedl, Melinda Gooderham. Dermatol Pract Concept 2022
Times Cited: 1

List of co-cited articles
articles co-cited >1

Times Cited
  Times     Co-cited

Long-term efficacy and safety of ixekizumab: A 5-year analysis of the UNCOVER-3 randomized controlled trial.
Andrew Blauvelt, Mark G Lebwohl, Tomotaka Mabuchi, Ann Leung, Alyssa Garrelts, Heidi Crane, Hany ElMaraghy, Himanshu Patel, Terri Ridenour, Kyoungah See,[...]. J Am Acad Dermatol 2021

Nail Psoriasis and Quality-of-Life Measurement in Clinical Trials: Call for the Use of Nail-Specific Instruments.
Christine Blome, Matthias Augustin, Toni Maria Klein. Am J Clin Dermatol 2021

Nail psoriasis in Germany: epidemiology and burden of disease.
M Augustin, K Reich, C Blome, I Schäfer, A Laass, M A Radtke. Br J Dermatol 2010

Biological disease-modifying antirheumatic drugs may mitigate the risk of psoriatic arthritis in patients with chronic plaque psoriasis.
Paolo Gisondi, Francesco Bellinato, Giovanni Targher, Luca Idolazzi, Giampiero Girolomoni. Ann Rheum Dis 2022

Network meta-analysis comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis.
Kristian Reich, Curdin Conrad, Lars Erik Kristensen, Saxon D Smith, Luis Puig, Phoebe Rich, Christophe Sapin, Thorsten Holzkaemper, Uffe Koppelhus, Christopher Schuster. J Dermatolog Treat 2022

Smoking and pathogenesis of psoriasis: a review of oxidative, inflammatory and genetic mechanisms.
A W Armstrong, E J Armstrong, E N Fuller, M E Sockolov, S V Voyles. Br J Dermatol 2011

A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 24-week efficacy and safety results from a randomized, double-blinded trial.
A Blauvelt, C Leonardi, B Elewski, J J Crowley, L C Guenther, M Gooderham, R G Langley, R Vender, A Pinter, C E M Griffiths,[...]. Br J Dermatol 2021

Ixekizumab and Ustekinumab Efficacy in Nail Psoriasis in Patients with Moderate-to-Severe Psoriasis: 52-Week Results from a Phase 3, Head-to-Head Study (IXORA-S).
Norman Wasel, Diamant Thaçi, Lars E French, Curdin Conrad, Yves Dutronc, Gaia Gallo, Lovisa Berggren, Jean-Philippe Lacour. Dermatol Ther (Heidelb) 2020

Efficacy and safety of ixekizumab in a phase III, randomized, double-blind, placebo-controlled study in paediatric patients with moderate-to-severe plaque psoriasis (IXORA-PEDS).
A S Paller, M M B Seyger, G Alejandro Magariños, J Bagel, A Pinter, J Cather, S Keller, C Rodriguez Capriles, R Gontijo Lima, G Gallo,[...]. Br J Dermatol 2020

Treating the skin with biologics in patients with psoriasis decreases the incidence of psoriatic arthritis.
Maria Laura Acosta Felquer, Luciano LoGiudice, Maria Laura Galimberti, Javier Rosa, Luis Mazzuoccolo, Enrique R Soriano. Ann Rheum Dis 2022

Ixekizumab for the treatment of psoriasis: up-to-date.
Sarah Craig, Richard B Warren. Expert Opin Biol Ther 2020

The effect of smoking on the psoriasis: Is it related to nail involvement?
Selami Aykut Temiz, İlkay Özer, Arzu Ataseven, Recep Dursun, Mehmet Uyar. Dermatol Ther 2020

Efficacy of ixekizumab on nail psoriasis in paediatric patients with moderate-to-severe psoriasis: a post hoc analysis from IXORA-PEDS.
M M B Seyger, A Reich, C El Baou, C Schuster, E Riedl, A S Paller. J Eur Acad Dermatol Venereol 2021

Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.